Literature DB >> 1544716

c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression.

H Tashiro1, K Miyazaki, H Okamura, A Iwai, M Fukumoto.   

Abstract

Expression of the c-myc gene was analyzed in 56 human primary ovarian cancer tissues, including 51 common epithelial and 5 non-epithelial tumours to determine molecular events in the carcinogenic process in ovaries. Over-expression of the c-myc gene was found in 37.3% of all ovarian tumour tissues, and in 63.5% of serous adenocarcinoma tissues. Significant over-expression of the c-myc gene at Stage III compared with other stages, and one remarkable case of over-expression in a serous tumour of low malignant potential suggest that c-myc expression is temporarily activated at some stage(s) during tumorigenesis of ovarian cancer, especially of serous tumours.

Entities:  

Mesh:

Year:  1992        PMID: 1544716     DOI: 10.1002/ijc.2910500528

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  BRCA1-mediated signaling pathways in ovarian carcinogenesis.

Authors:  Tejaswita M Karve; Xin Li; Tapas Saha
Journal:  Funct Integr Genomics       Date:  2011-09-02       Impact factor: 3.410

2.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

4.  PAX8 expression in ovarian surface epithelial cells.

Authors:  Emily Adler; Paulette Mhawech-Fauceglia; Simon A Gayther; Kate Lawrenson
Journal:  Hum Pathol       Date:  2015-04-15       Impact factor: 3.466

5.  Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival.

Authors:  M E McMenamin; A J O'Neill; E F Gaffney
Journal:  Mol Pathol       Date:  1997-10

6.  DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.

Authors:  J Diebold; B Suchy; G B Baretton; S Blasenbreu; W Meier; M Schmidt; H Rabes; U Löhrs
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

7.  Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.

Authors:  Yali Zhai; Rong Wu; Donald R Schwartz; Danielle Darrah; Heather Reed; Frank T Kolligs; Marvin T Nieman; Eric R Fearon; Kathleen R Cho
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

8.  Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

Authors:  Mingyi Wang; Jian Wang; Lin Wang; Liying Wu; Xiaoyan Xin
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

9.  Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

Authors:  Haiyan Zhao; Hao Xu; Luchen Xue
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

10.  An RGDKGE-Containing Cryptic Collagen Fragment Regulates Phosphorylation of Large Tumor Suppressor Kinase-1 and Controls Ovarian Tumor Growth by a Yes-Associated Protein-Dependent Mechanism.

Authors:  XiangHua Han; Jennifer M Caron; Christine W Lary; Pradeep Sathyanarayana; Calvin Vary; Peter C Brooks
Journal:  Am J Pathol       Date:  2020-12-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.